⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 3, 2019Ophthalmology and TherapyOpen Access

Evaluating Patient Experiences in Dry Eye Disease Through Social Media Listening Research

Nigel S. Cook Anmol Mullins Raju Gautam Sharath Medi C Prince Nishith Tyagi Jyothi Kommineni

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Novartis Pharma AG, Basel, Switzerland. Plain language summary available for this article.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cook et al. (2019) studied this question.

synapsesocial.com/papers/69d920c88988aeabbe684340 https://doi.org/10.1007/s40123-019-0188-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1TFOS DEWS II Report Executive SummaryOriginal Research · 2017 · 851 citations
2Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and OlderCross-Sectional Study · 2017 · 568 citations
3Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature ReviewSystematic Review · 2015 · 325 citations
4Patterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes ResearchReview · 2016 · 41 citations
5Using Social Media to Characterize Public Sentiment Toward Medical Interventions Commonly Used for Cancer Screening: An Observational StudyObservational Study · 2017 · 42 citations

More related papers

Leveraging Social Media to Explore Black Women's Perspectives on HIV Pre-exposure Prophylaxis2017
Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease2017
What Are People Tweeting About Zika? An Exploratory Study Concerning Its Symptoms, Treatment, Transmission, and Prevention2017

More from Ophthalmology and Therapy

Real-World Longitudinal Outcomes of First-Line Aflibercept 8 mg for Treatment-Naïve Diabetic Macular EdemaThu,
Aqueous and Vitreous Ketorolac Levels in Combined Cataract and Pars Plana Vitrectomy with Intracameral Ketorolac 0.3% Versus Topical Ketorolac 0.4%Thu,